Trial Profile
A study evaluating efficacy and tolerability of clean intermittent catheterization and catheterization during sleep combined with tolterodine in children with neurogenic detrusor overactivity.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 29 Nov 2017 New trial record